Challenges for the Application and Development of OMICs Health Technologies in Developing Countries

Farah Huzair, Alexander Borda-rodriguez

Research output: Contribution to journalArticlepeer-review

Abstract

Omics technologies and particular applications for diagnostics and pharmacogenomics, can potentially identify disease risk, reduce disease burden, and provide better and more cost-effective health care. International institutions have recognized that global justice necessitates equity of access to medical technologies for developing and well as developed countries. The promise of the omics technologies may remain unfulfilled for developing countries unless capacities for exploitation and integration are created. These capacities are those that enable contribution efforts to upstream data collection and innovation, and downstream governance and regulation.
Original languageEnglish
Pages (from-to)447-451
JournalDrug Development Research
Volume73
Issue number7
Early online date18 Oct 2012
DOIs
Publication statusPublished - Nov 2012

Keywords

  • omics
  • postgenomics
  • global justice
  • developing countries
  • regulation
  • governance
  • capacities

Fingerprint

Dive into the research topics of 'Challenges for the Application and Development of OMICs Health Technologies in Developing Countries'. Together they form a unique fingerprint.

Cite this